News

Microfluidics claimed that the LV1, which operates with the same fixed-geometry interaction chamber technology of larger volume machines, brings better capabilities for uniform particle size reduction and cell

LCZ696 is a novel-acting compound with distinctive chemical and biological properties; upon oral administration, it simultaneously inhibits both NEP and the angiotensin receptor. By targeting these two neurohormonal

The newly developed IDD discovery platform enables the in silico identification of peptide sequences that are predicted to have the potential to penetrate the cell membrane. The new

Dishman Pharma, through synthetic chemistry research, has developed manufacturing processes for various intermediates, APIs, quarternary ammonium compounds (QUATS) and specialty chemicals. Dishman is a global outsourcing partner for

Prosonix claimed that the technology, which was made commercially available this month, uses a highly specialised new variant of the company’s sonocrystallisation technique to make active pharmaceutical ingredient

The approval for both Vit Kit-Freeze and Vit Kit-Thaw allows users greater flexibility to vitrify specimens depending on the in-vitro fertilization (IVF) laboratory’s protocol and their patients’ needs.

The Phase 3 study is an 18-month randomised, parallel group, double-blind, placebo controlled trial evaluating the efficacy and safety of Olesoxime against placebo in patients diagnosed with ALS

Biocor said that PLA can be completely converted back into its fundamental building block, lactic acid, and then reformulated into a biopolymer. PLA can also be commercially composted

The new SphygmoCor offers improvements to simplify clinical use, and will assist evaluation of cardiovascular status and management of patient care by medical specialists, particularly cardiologists, hypertension specialists,